PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $2,384,000 | -70.1% | 334,366 | 0.0% | 0.03% | -65.3% |
Q4 2019 | $7,985,000 | -11.0% | 334,366 | 0.0% | 0.10% | -16.7% |
Q3 2019 | $8,968,000 | -1.1% | 334,366 | 0.0% | 0.11% | +0.9% |
Q2 2019 | $9,071,000 | +64.0% | 334,366 | +109.8% | 0.11% | +61.4% |
Q1 2019 | $5,530,000 | +77.8% | 159,366 | 0.0% | 0.07% | +55.6% |
Q4 2018 | $3,111,000 | -47.8% | 159,366 | -28.8% | 0.04% | -41.6% |
Q3 2018 | $5,957,000 | +6.9% | 223,682 | +51.6% | 0.08% | 0.0% |
Q2 2018 | $5,574,000 | +84.3% | 147,587 | +59.4% | 0.08% | +67.4% |
Q1 2018 | $3,024,000 | -40.6% | 92,599 | -11.5% | 0.05% | -37.8% |
Q4 2017 | $5,095,000 | -23.2% | 104,671 | -14.8% | 0.07% | -21.3% |
Q3 2017 | $6,635,000 | +22.3% | 122,801 | +27.1% | 0.09% | +14.6% |
Q2 2017 | $5,425,000 | +11.1% | 96,590 | -22.5% | 0.08% | -1.2% |
Q1 2017 | $4,881,000 | +90.5% | 124,553 | +9.1% | 0.08% | +69.4% |
Q4 2016 | $2,562,000 | -10.5% | 114,180 | -9.5% | 0.05% | -2.0% |
Q3 2016 | $2,864,000 | +135.5% | 126,113 | +144.8% | 0.05% | +117.4% |
Q2 2016 | $1,216,000 | +15.7% | 51,513 | 0.0% | 0.02% | +15.0% |
Q1 2016 | $1,051,000 | -60.3% | 51,513 | 0.0% | 0.02% | -56.5% |
Q4 2015 | $2,650,000 | -19.3% | 51,513 | -33.1% | 0.05% | -16.4% |
Q3 2015 | $3,282,000 | -53.2% | 77,013 | -50.0% | 0.06% | +10.0% |
Q2 2015 | $7,016,000 | +198.0% | 154,026 | +148.4% | 0.05% | +47.1% |
Q1 2015 | $2,354,000 | +124.6% | 62,013 | +67.5% | 0.03% | +126.7% |
Q4 2014 | $1,048,000 | -22.8% | 37,013 | -30.1% | 0.02% | -25.0% |
Q3 2014 | $1,358,000 | – | 52,932 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|